In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: AMN Healthcare trades well below its PERT-weighted fair value of $79.76, implying substantial upside potential near 159%. Despite weak profitability and efficiency scores, Monte Carlo analysis shows zero downside risk below current price with high valuation volatility. The discrepancy between strong growth and poor financial health signals elevated investment risk amid significant opportunity.